|
09 Feb 2007 |
Advanced BioHealing Enrolls First Patient in Celaderm Pilot Venous Leg Ulcer Clinical Trial
|
|
09 Feb 2007 |
Advanced BioHealing Enrolls First Patient in Celaderm Pilot Venous Leg Ulcer Clinical Trial
|
|
09 Feb 2007 |
GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
|
|
09 Feb 2007 |
SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate
|
|
09 Feb 2007 |
BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
|
|
09 Feb 2007 |
BioSyntech announces start of patient recruitment into BST-DermOn(TM) pivotal clinical trial
|
|
08 Feb 2007 |
Ranbaxy Announces Global Entry Into Biosimilars With Zenotech
|
|
08 Feb 2007 |
Lupin Pharmaceuticals, Inc. Receives US FDA Approval For Sertraline
|
|
07 Feb 2007 |
ImClone Systems Opts-out of Development Agreement with UCB to Focus Resources on Proprietary, Anti-VEGFr-2 Antibody IMC-1121B
|
|
07 Feb 2007 |
Ranbaxy Signs A New R&D Agreement With Gsk
|
|
07 Feb 2007 |
Mylan Announces Final FDA Approval for Sertraline Hydrochloride Tablets
|
|
07 Feb 2007 |
KineMed and Bayer Healthcare AG Enter Collaboration to Discover New Therapeutic Applications for Drug Candidates
|
|
07 Feb 2007 |
Barr's Subsidiary PLIVA Receives Final Approval for Generic ZOLOFT(R) Tablets, 25 mg, 50 mg and 100 mg
|
|
06 Feb 2007 |
AstraZeneca Licenses Regeneron's Velocimmune(R) Technology For Discovering Human Monoclonal Antibodies
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and MediVas Announce Research Partnership to Develop Advanced Hemophilia Therapies
|
|
06 Feb 2007 |
Wyeth Pharmaceuticals and Nautilus Biotech Announce Collaboration to Develop Hemophilia Therapies
|
|
06 Feb 2007 |
Roche continues to strengthen Research and Development
|
|
06 Feb 2007 |
Antisense Therapeutics Extends its Drug Discovery and Development Collaboration with Isis Pharmaceuticals
|
|
06 Feb 2007 |
elbion and Wyeth Enter Collaboration to Develop New Treatments for Schizophrenia
|
|
06 Feb 2007 |
UCB Licenses BioWa's POTELLIGENT(R) Technology for use in Antibody Research and Development
|
|
05 Feb 2007 |
Diabetes Prevalence
|
|
03 Feb 2007 |
Tanabe Seiyaku Co., Ltd. and Mitsubishi Pharma Corporation Enter into A Basic Agreement to Merge on October 1, 2007
|
|
03 Feb 2007 |
Schering-Plough Cites Today's Anacor Agreement as Latest in Series of Deals
|
|
03 Feb 2007 |
Biodelivery Sciences Announces FDA Acceptance of Bioral Amphotericin IND
|
